Clinical Trial Details
EORTC-22996-24002
Back to Clinical Trials Database
A phase III double-blind, randomized, placebo-controlled study of Erythropoietin when used as an adjuvant to radiation therapy in patients with head and neck squamous cell carcinoma. EORTC 22996-24002
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 12-Mar-2001 Date Step1 close: 04-Apr-2003 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 762 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00017277 |
| NCT number | NCT00017277 |
